NCT01581866View on ClinicalTrials.gov

Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

January 31, 2005

Conditions
Healthy
Interventions
DRUG

Ziprasidone Hydrochloride

Ziprasidone HCL Capsules, 20 mg

Trial Locations (1)

33901

SFBC Ft. Myers, Inc., Fort Myers

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY